三重阴性乳腺癌系统治疗:破坏性的早期发展,以克服先进管道停滞的局面
Carlos Alonso-Ron1, Andrea Vethencourt2,3,4, Eva González-Suárez1,2
1Spanish National Cancer Research Center (CNIO), 28029 Madrid, Spain.
Cancers
|February 26, 2025
概括
三阴性乳腺癌 (TNBC) 缺乏共同的点,使化疗成为标准. 然而,对于这种侵袭性疾病,研究正在推进新型免疫疗法和精确瘤治疗方法.
科学领域:
- 在瘤学瘤学.
- 医学研究 医学研究
背景情况:
- 乳腺癌 (BC) 诊断在全球范围内不断增加,三阴性乳腺癌 (TNBC) 占15-25%的病例.
- 由于缺乏雌激素受体 (ER),孕激素受体 (PR) 和HER2过度表达,TNBC具有侵略性,限制了向治疗选择.
研究的目的:
- 审查TNBC目前的治疗环境.
- 突出正在进行的研究和TNBC的新兴疗法.
主要方法:
- 审查TNBC目前的全身治疗方法,包括化疗和向疗法.
- 讨论早期试验中的新兴疗法,重点是免疫疗法和精确瘤学.
主要成果:
- 化疗仍然是TNBC的主要治疗方法.
- 针对性疗法,如PARP抑制剂 (针对BRCA突变的TNBC),免疫检查点抑制剂和抗体-药物结合物,在特定亚型中表现有前途.
- 针对PI3K/Akt/mTOR和CDK4/6等途径的研究疗法尚未在TNBC中产生令人信服的结果.
结论:
- 尽管面临挑战,但由未满足的医疗需求驱动的强烈研究正在为TNBC产生颠覆性的治疗方法.
- 在TNBC治疗的早期试验中,正在探索免疫疗法和精确瘤学的新目标和前沿进展.
相关概念视频
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy
462
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
462
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Vaccines
325
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
325
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K


